March 20, 2026
Olive AI was once one of the most recognized names in healthcare AI, raising over $900M for its automation platform. After significant restructuring, many organizations that were evaluating or using Olive are now seeking alternatives that deliver on the promise of healthcare AI automation.
Olive's core appeal was automating repetitive healthcare workflows: eligibility verification, claims processing, prior authorization, and revenue cycle tasks. These needs haven't changed. Healthcare organizations still spend hundreds of billions annually on administrative overhead.
Olive relied on Robotic Process Automation — software mimicking human clicks. Modern platforms deploy autonomous agents that understand clinical context, make decisions, and communicate with patients through natural language across phone, text, and portal channels.
The new generation automates clinical care workflows: patient outreach, care coordination, post-discharge follow-up, medication management, chronic disease monitoring, and quality measure closure.
Modern platforms integrate data, intelligence, agents, and care plans into unified operating systems. A single platform handles everything from data ingestion through patient outcome documentation.
Zynix AI combines the automation promise that attracted organizations to Olive with next-generation AI agent capabilities. The platform deploys 12 specialized AI agents, executes deployable care plans, and delivers measurable outcomes: 85%+ TCM contact rates, 2-3x AWV improvement, and 40% better gap closure — all within 30-60 days.
When evaluating Olive AI alternatives, prioritize: clinical workflow automation (not just admin), autonomous agent capabilities, healthcare-native AI models, EHR integration depth, implementation speed, and measurable outcome guarantees.